What is the appropriate evaluation and management for a 30-year-old woman with prolonged menstrual bleeding?

Evaluation and Management of Prolonged Menstrual Bleeding in a 30-Year-Old Woman

For a 30-year-old woman with prolonged menstrual bleeding, begin with a pregnancy test, TSH, prolactin, and CBC, followed by transvaginal ultrasound to rule out structural causes, then initiate first-line medical management with either the levonorgestrel-releasing intrauterine system (LNG-IUS) or combined oral contraceptives 1.

Initial Evaluation

Essential History Elements

Focus on:

• Bleeding pattern specifics: Duration (>8 days suggests heavy menstrual bleeding), frequency, volume indicators (clots ≥1 inch, "flooding" requiring pad/tampon changes more than hourly) 2
• Risk factors for endometrial pathology: Age >35 years, obesity, diabetes, PCOS, chronic anovulation 3
• Bleeding disorder indicators: Personal or family history of bleeding symptoms, easy bruising 2
• Contraceptive needs and fertility desires

Laboratory Assessment

• Pregnancy test (β-hCG) - mandatory first step 1
• TSH and prolactin - to identify ovulatory dysfunction 1
• CBC - assess for anemia 2
• Consider coagulation studies if history suggests bleeding disorder (up to 20% of women with heavy menstrual bleeding have an inherited bleeding disorder) 4

Imaging

Transvaginal ultrasound is the ideal first-line imaging modality 5. This evaluates for structural causes using the PALM-COEIN classification system 1:

• Structural causes (PALM): Polyps, Adenomyosis, Leiomyoma, Malignancy/hyperplasia
• Non-structural causes (COEIN): Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not classified

If ultrasound cannot adequately visualize the endometrium, saline infusion sonohysterography has 96-100% sensitivity and 94-100% negative predictive value for detecting uterine pathology 1.

Endometrial Sampling Considerations

At age 30, endometrial biopsy is not routinely required unless specific risk factors are present 3:

• Recurrent anovulation with risk factors for endometrial cancer
• Excessive bleeding unresponsive to medical therapy
• Ultrasound findings suggesting endometrial pathology

Endometrial biopsy is preferred over dilation and curettage due to lower invasiveness, better safety profile, and lower cost 1.

Medical Management (First-Line)

Once structural and malignant causes are excluded, medical management is the first-line approach 6.

Most Effective Options

1. Levonorgestrel-releasing intrauterine system (LNG-IUS)

• Most effective long-term treatment for heavy menstrual bleeding 6, 4
• At 10-year follow-up, 43% of women continue using LNG-IUS with good outcomes 7
• Can be used alone or combined with other treatments
• Provides contraception

2. Combined oral contraceptives

• Effective for regulating cycles in ovulatory dysfunction 1
• Appropriate if contraception desired and no contraindications
• Can be used in multidose regimens for acute bleeding 6

3. Oral progestins

• Continuous or cyclic regimens effective 6
• Particularly useful for anovulatory bleeding 1

4. Tranexamic acid

• Reduces menstrual blood loss by 40-50% 4
• Can be used alone or combined with hormonal methods 6
• FDA-approved for ovulatory bleeding 3

5. NSAIDs (mefenamic acid)

• Reduce menstrual blood loss by 20-30% 3
• Can be combined with hormonal methods 6

When Medical Management Fails

If medical treatment fails, is contraindicated, or not tolerated, proceed with further investigation 1:

1. Hysteroscopy - allows direct visualization of endometrial cavity and can diagnose focal lesions missed by sampling 1

2. MRI with diffusion-weighted imaging - when ultrasound inadequate, particularly with fibroids or adenomyosis obscuring endometrial visualization 8

3. Surgical options (if medical management unsuccessful):

   • Endometrial ablation (not first-line, requires counseling about long-term complications including delayed cancer diagnosis) 1
   • Hysterectomy (definitive treatment) 3

Critical Pitfalls to Avoid

• Do not assume dysfunctional bleeding without excluding structural causes - transvaginal ultrasound is essential 5
• Do not overlook bleeding disorders - they affect up to 20% of women with heavy menstrual bleeding 4
• Do not perform endometrial ablation without proper counseling about risks including postablation complications and delayed endometrial cancer diagnosis 1
• Do not use transvaginal ultrasound in virgins - use transabdominal imaging instead 1

Treatment Algorithm Summary

1. Rule out pregnancy (β-hCG)
2. Assess for systemic causes (TSH, prolactin, CBC)
3. Perform transvaginal ultrasound to exclude structural pathology
4. Initiate medical management: LNG-IUS preferred for long-term efficacy, or combined oral contraceptives/progestins based on contraceptive needs
5. Add tranexamic acid or NSAIDs if hormonal therapy alone insufficient
6. Reassess at 3-6 months - if treatment fails, proceed to hysteroscopy or advanced imaging
7. Consider surgical options only after medical management failure

The evidence strongly supports medical management as first-line therapy with high success rates and low surgical intervention rates (only 17% hysterectomy, 13% ablation at 10-year follow-up) 7.